Itaconix Plc engages in designing, developing, and formulating novel polymers to improve the performance of existing consumer products. The company is headquartered in Stratham, New Hampshire and currently employs 22 full-time employees. The company went IPO on 2012-07-10. The Company’s principal activities are the development of plant-based polymers, and the production and sale of these materials globally, both directly and through partners as ingredients in product formulations. The Company’s segments include Itaconix Performance Ingredients, SPARX Formulated Solutions, and BIO*Asterix. Itaconix Performance Ingredients develops, produces, and sells proprietary specialty polymers that are used as functional ingredients to meet customer needs in cleaning, beauty and hygiene products. SPARX Formulated Solutions provides technical services and ingredient supplies for formulated products developed for customers based on Performance Ingredients. BIO*Asterix develops, produces, and sells specialty itaconate monomers as plant-based alternatives to acrylates and styrenes in paint, coating, and adhesive applications.
Mr. John Shaw es el Chief Executive Officer de Itaconix PLC, se unió a la empresa desde 2018.
¿Qué tal es el rendimiento del precio de la acción ITXXF?
El precio actual de ITXXF es de $1.2, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Itaconix PLC?
Itaconix PLC pertenece a la industria Chemicals y el sector es Materials
¿Cuál es la capitalización bursátil de Itaconix PLC?
La capitalización bursátil actual de Itaconix PLC es $16.1M
¿Es Itaconix PLC una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Itaconix PLC, incluyendo 3 fuerte compra, 5 compra, 1 mantener, 0 venta, y 3 fuerte venta